A esclerose lateral amiotrófica (ELA) é uma doença neurológica que piora com o tempo. Ela se caracteriza por uma fraqueza e paralisia progressiva dos músculos, que acontece porque os neurônios motores — as células nervosas que controlam os movimentos — morrem ou ficam enfraquecidos. Isso ocorre em partes do cérebro que controlam os movimentos, nas vias nervosas que ligam o cérebro à medula, no tronco cerebral e na medula espinhal.
Introdução
O que você precisa saber de cara
A esclerose lateral amiotrófica (ELA) é uma doença neurológica que piora com o tempo. Ela se caracteriza por uma fraqueza e paralisia progressiva dos músculos, que acontece porque os neurônios motores — as células nervosas que controlam os movimentos — morrem ou ficam enfraquecidos. Isso ocorre em partes do cérebro que controlam os movimentos, nas vias nervosas que ligam o cérebro à medula, no tronco cerebral e na medula espinhal.
Tem tratamento?
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 115 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 245 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
46 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, Not applicable.
Forms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding (PubMed:10799849). Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor protein APP, and mediates its uptake and degradation by microglia (PubMed:27477018, PubMed:29518356). Binding to amyloid-beta 42 mediates microglial activation, proliferation, migration, apoptosis and expression of pro-inflammatory cytokines, such as IL6R and CCL3, a
Cell membraneSecreted
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2
An autosomal recessive disease characterized by presenile frontal dementia with leukoencephalopathy and basal ganglia calcification. In most cases the disorder first manifests in early adulthood as pain and swelling in ankles and feet, followed by bone fractures. Neurologic symptoms manifest in the fourth decade of life as a frontal lobe syndrome with loss of judgment, euphoria, and disinhibition. Progressive decline in other cognitive domains begins to develop at about the same time. The disorder culminates in a profound dementia and death by age 50 years.
Probable receptor, which may be involved in the internalization of lipophilic molecules and/or signal transduction. May act as a tumor suppressor
MembraneMembrane, coated pit
Oculopharyngodistal myopathy 1
A form of oculopharyngodistal myopathy, a muscle disorder characterized by progressive ptosis, external ophthalmoplegia, and weakness of the masseter, facial, pharyngeal, and distal limb muscles. The myopathological features are presence of rimmed vacuoles in the muscle fibers and myopathic changes of differing severity. OPDM1 inheritance pattern is autosomal dominant.
May act as a GTPase regulator. Controls survival and growth of spinal motoneurons (By similarity)
Amyotrophic lateral sclerosis 2
A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.
RNA-binding protein involved in the regulation of alternative pre-RNA splicing and mRNA translation by binding to uridine-rich (U-rich) RNA sequences (PubMed:11106748, PubMed:12486009, PubMed:17488725, PubMed:8576255). Binds to U-rich sequences immediately downstream from a 5' splice sites in a uridine-rich small nuclear ribonucleoprotein (U snRNP)-dependent fashion, thereby modulating alternative pre-RNA splicing (PubMed:11106748, PubMed:8576255). Preferably binds to the U-rich IAS1 sequence in
NucleusCytoplasmCytoplasm, Stress granule
Welander distal myopathy
An autosomal dominant disorder characterized by adult onset of distal muscle weakness predominantly affecting the distal long extensors of the hands, with slow progression to involve all small hand muscles and the lower legs. Skeletal muscle biopsy shows myopathic changes and prominent rimmed vacuoles. Rare homozygous patients showed earlier onset, faster progression, and proximal muscle involvement.
May play a role in neurite plasticity by maintaining cytoskeleton stability and regulating synaptic vesicle transport
Cytoplasm, cytosolNucleusCell projection, axonCell projection, dendrite
Spastic paraplegia 11, autosomal recessive
A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.
Component of the serine palmitoyltransferase multisubunit enzyme (SPT) that catalyzes the initial and rate-limiting step in sphingolipid biosynthesis by condensing L-serine and activated acyl-CoA (most commonly palmitoyl-CoA) to form long-chain bases. The SPT complex is also composed of SPTLC2 or SPTLC3 and SPTSSA or SPTSSB. Within this complex, the heterodimer with SPTLC2 or SPTLC3 forms the catalytic core (PubMed:19416851, PubMed:33558762, PubMed:36170811). The composition of the serine palmit
Endoplasmic reticulum membrane
Amyotrophic lateral sclerosis 27, juvenile
A form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. ALS27 is an autosomal dominant form manifesting as toe walking and gait abnormalities in early childhood.
Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin
Cytoplasm, cytoskeleton
Frontotemporal dementia and/or amyotrophic lateral sclerosis 9
An autosomal dominant neurodegenerative disorder characterized by adult onset of frontotemporal dementia or amyotrophic lateral sclerosis with upper and lower neuron involvement. Some patients manifest both frontotemporal dementia and amyotrophic lateral sclerosis.
ATP-dependent 5'->3' DNA/RNA helicase that preferentially unwinds RNA substrates over DNA, playing a crucial role in resolving R-loops and promoting transcription termination (PubMed:36864660). Plays a role in transcription regulation by its ability to modulate RNA Polymerase II (Pol II) binding to chromatin and through its interaction with proteins involved in transcription (PubMed:19515850, PubMed:21700224). Contributes to the mRNA splicing efficiency and splice site selection (PubMed:19515850
NucleusNucleus, nucleoplasmNucleus, nucleolusCytoplasmChromosomeChromosome, telomereCell projection, axonCell projection, growth cone
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAN2 is an autosomal recessive form associated with peripheral neuropathy and elevated serum alpha-fetoprotein, immunoglobulins and, less commonly, creatine kinase levels. Some SCAN2 patients manifest oculomotor apraxia.
Deubiquitinase that specifically cleaves 'Lys-63'- and linear 'Met-1'-linked polyubiquitin chains and is involved in NF-kappa-B activation and TNF-induced necroptosis (PubMed:18313383, PubMed:18636086, PubMed:26670046, PubMed:26997266, PubMed:27458237, PubMed:27591049, PubMed:27746020, PubMed:29291351, PubMed:32185393). Negatively regulates NF-kappa-B activation by deubiquitinating upstream signaling factors (PubMed:12917689, PubMed:12917691, PubMed:32185393). Contributes to the regulation of ce
CytoplasmCytoplasm, perinuclear regionCytoplasm, cytoskeletonCell membraneCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, cilium basal body
Cylindromatosis, familial
A disorder characterized by multiple skin tumors that develop from skin appendages, such as hair follicles and sweat glands. Affected individuals typically develop large numbers of tumors called cylindromas that arise predominantly in hairy parts of the body with approximately 90% on the head and neck. In severely affected individuals, cylindromas may combine into a confluent mass which may ulcerate or become infected (turban tumor syndrome). Individuals with familial cylindromatosis occasionally develop other types of tumors including spiradenomas that begin in sweat glands, and trichoepitheliomas arising from hair follicles.
Functions in lipid transport from the endoplasmic reticulum and is involved in a wide array of cellular functions probably through regulation of the biogenesis of lipid microdomains at the plasma membrane. Involved in the regulation of different receptors it plays a role in BDNF signaling and EGF signaling. Also regulates ion channels like the potassium channel and could modulate neurotransmitter release. Plays a role in calcium signaling through modulation together with ANK2 of the ITP3R-depend
Nucleus inner membraneNucleus outer membraneNucleus envelopeCytoplasmic vesicleEndoplasmic reticulum membraneMembraneLipid dropletCell junctionCell membraneCell projection, growth conePostsynaptic density membrane
Amyotrophic lateral sclerosis 16, juvenile
A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.
Acts as a guanine-nucleotide releasing factor (GEF) for Rab GTPases by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP (PubMed:27103069, PubMed:27193190, PubMed:27617292, PubMed:28195531, PubMed:37821429). Acts as a GEF for RAB39A which enables HOPS-mediated autophagosome-lysosome membrane tethering and fusion in mammalian autophagy (PubMed:37821429). Component of the C9orf72-SMCR8 complex where both subunits display GEF activity and that regulates autophagy (PubMed:27103
CytoplasmNucleusCytoplasm, P-bodyCytoplasm, Stress granuleEndosomeLysosomeCytoplasmic vesicle, autophagosomeAutolysosomeSecretedCell projection, axonCell projection, growth conePerikaryonCell projection, dendritePresynapsePostsynapseNucleus membrane
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
An autosomal dominant neurodegenerative disorder characterized by adult onset of frontotemporal dementia and/or amyotrophic lateral sclerosis in an affected individual. There is high intrafamilial variation. Frontotemporal dementia is characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Amyotrophic lateral sclerosis is characterized by the death of motor neurons in the brain, brainstem, and spinal cord, resulting in fatal paralysis.
Required for the export of mRNAs containing poly(A) tails from the nucleus into the cytoplasm. May be involved in the terminal step of the mRNA transport through the nuclear pore complex (NPC)
NucleusCytoplasmNucleus, nuclear pore complex
Lethal congenital contracture syndrome 1
A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy, and congenital non-progressive joint contractures (arthrogryposis). The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS1 patients manifest early fetal hydrops and akinesia, micrognathia, pulmonary hypoplasia, pterygia, and multiple joint contractures. It leads to prenatal death.
Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins and EGF family members and regulates development of the heart, the central nervous system and the mammary gland, gene transcription, cell proliferation, differentiation, migration and apoptosis. Required for normal cardiac muscle differentiation during embryonic development, and for postnatal cardiomyocyte proliferation. Required for normal development of the embryonic central nervous system, especially
Cell membraneNucleusMitochondrion
Amyotrophic lateral sclerosis 19
A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.
Dual specificity phosphatase component of the PI(3,5)P2 regulatory complex which regulates both the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) (PubMed:17556371, PubMed:33098764). Catalyzes the dephosphorylation of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) to form phosphatidylinositol 3-phosphate (PubMed:33098764). Has serine-protein phosphatase activity acting on PIKfyve to stimulate its lipid kinase activity, its catalytically activity being requ
Endosome membrane
Charcot-Marie-Tooth disease, demyelinating, type 4J
A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4.
Essential for retina photoreceptor outer segment disk morphogenesis, may also play a role with ROM1 in the maintenance of outer segment disk structure (By similarity). Required for the maintenance of retinal outer nuclear layer thickness (By similarity). Required for the correct development and organization of the photoreceptor inner segment (By similarity)
MembraneCell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment
Retinitis pigmentosa 7
A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:20596027, PubMed:22632967, PubMed:26818844, PubMed:27080313, PubMed:27653696, PubMed:28852778). The SCF(CCNF) E3 ubiquitin-protein ligase complex is an integral component of the ubiquitin proteasome system (UPS) and links proteasome degradation to the cell cycle (PubMed:20596027, PubMed:26818844,
NucleusCytoplasm, perinuclear regionCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole
Frontotemporal dementia and/or amyotrophic lateral sclerosis 5
A neurodegenerative disorder characterized by frontotemporal dementia and/or amyotrophic lateral sclerosis in affected individuals. There is high intrafamilial variation. Frontotemporal dementia is characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Amyotrophic lateral sclerosis is characterized by the death of motor neurons in the brain, brainstem, and spinal cord, resulting in fatal paralysis. FTDALS5 is an autosomal dominant form with age-dependent penetrance. Penetrance is estimated to be 50% by age 56 and 100% by age 61.
Endoplasmic reticulum (ER)-anchored protein that mediates the formation of contact sites between the ER and endosomes via interaction with FFAT motif-containing proteins such as STARD3 or WDR44 (PubMed:32344433, PubMed:33124732). Interacts with STARD3 in a FFAT motif phosphorylation dependent manner (PubMed:33124732). Via interaction with WDR44 participates in neosynthesized protein export (PubMed:32344433). Participates in the endoplasmic reticulum unfolded protein response (UPR) by inducing ER
Endoplasmic reticulum membrane
Amyotrophic lateral sclerosis 8
A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.
Involved in EGFR trafficking, acting as negative regulator of endocytic EGFR internalization at the plasma membrane
Cytoplasm
Spinocerebellar ataxia 2
Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA2 is characterized by hyporeflexia, myoclonus and action tremor and dopamine-responsive parkinsonism. In some patients, SCA2 presents as pure familial parkinsonism without cerebellar signs.
The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription (PubMed:33795473). TFIID recognizes and binds promoters with or without a TATA box via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC) (PubMed:33795473). The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 an
Nucleus
Plays an important role in the maintenance of the Golgi complex, in membrane trafficking, in exocytosis, through its interaction with myosin VI and Rab8 (PubMed:27534431). Links myosin VI to the Golgi complex and plays an important role in Golgi ribbon formation (PubMed:27534431). Plays a role in the activation of innate immune response during viral infection. Mechanistically, recruits TBK1 at the Golgi apparatus, promoting its trans-phosphorylation after RLR or TLR3 stimulation (PubMed:27538435
Cytoplasm, perinuclear regionGolgi apparatusGolgi apparatus, trans-Golgi networkCytoplasmic vesicle, autophagosomeCytoplasmic vesicleRecycling endosome
Glaucoma 1, open angle, E
A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place.
Transcriptional coactivator for steroid receptors and nuclear receptors (PubMed:10713165, PubMed:20005308, PubMed:21376232, PubMed:28363985, PubMed:32433991). Greatly increases the transcriptional activity of PPARG and thyroid hormone receptor on the uncoupling protein promoter (PubMed:10713165, PubMed:20005308, PubMed:21376232). Can regulate key mitochondrial genes that contribute to the program of adaptive thermogenesis (PubMed:10713165, PubMed:20005308, PubMed:21376232). Plays an essential ro
NucleusNucleus, PML bodyCytoplasm
May be involved in the maintenance of mitochondrial organization and mitochondrial cristae structure
Mitochondrion intermembrane space
Frontotemporal dementia and/or amyotrophic lateral sclerosis 2
A neurodegenerative disorder characterized by frontotemporal dementia and/or amyotrophic lateral sclerosis in affected individuals. There is high intrafamilial variation. Frontotemporal dementia is characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Amyotrophic lateral sclerosis is characterized by the death of motor neurons in the brain, brainstem, and spinal cord, resulting in fatal paralysis.
Plays an important role in the regulation of different protein degradation mechanisms and pathways including ubiquitin-proteasome system (UPS), autophagy and the endoplasmic reticulum-associated protein degradation (ERAD) pathway. Mediates the proteasomal targeting of misfolded or accumulated proteins for degradation by binding (via UBA domain) to their polyubiquitin chains and by interacting (via ubiquitin-like domain) with the subunits of the proteasome (PubMed:10983987). Plays a role in the E
CytoplasmNucleusMembraneCytoplasmic vesicle, autophagosome
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia
A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. Patients with ALS15 may develop frontotemporal dementia.
In vitro, catalyzes the transfer of a galactose residue from UDP-galactose onto GalNAc and GlcNAc structures
Golgi apparatus membrane
Destroys radicals which are normally produced within the cells and which are toxic to biological systems (PubMed:24140062). Catalyzes the oxidation of hydrogen sulfide (H2S) to sulfate, playing an important role in detoxifying H2S and limiting the accumulation of reactive sulfur species (RSS) such as persulfides and polysulfides (PubMed:36630448)
CytoplasmNucleus
Amyotrophic lateral sclerosis 1
A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.
Acts as a guanine-nucleotide releasing factor (GEF) for Rab GTPases by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP (PubMed:27103069, PubMed:27193190, PubMed:27617292, PubMed:28195531, PubMed:37821429). Acts as a GEF for RAB39A which enables HOPS-mediated autophagosome-lysosome membrane tethering and fusion in mammalian autophagy (PubMed:37821429). Component of the C9orf72-SMCR8 complex where both subunits display GEF activity and that regulates autophagy (PubMed:27103
CytoplasmNucleusCytoplasm, P-bodyCytoplasm, Stress granuleEndosomeLysosomeCytoplasmic vesicle, autophagosomeAutolysosomeSecretedCell projection, axonCell projection, growth conePerikaryonCell projection, dendritePresynapsePostsynapseNucleus membrane
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
An autosomal dominant neurodegenerative disorder characterized by adult onset of frontotemporal dementia and/or amyotrophic lateral sclerosis in an affected individual. There is high intrafamilial variation. Frontotemporal dementia is characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Amyotrophic lateral sclerosis is characterized by the death of motor neurons in the brain, brainstem, and spinal cord, resulting in fatal paralysis.
Serine/threonine kinase that plays an essential role in regulating inflammatory responses to foreign agents (PubMed:10581243, PubMed:11839743, PubMed:12692549, PubMed:12702806, PubMed:14703513, PubMed:15367631, PubMed:15485837, PubMed:18583960, PubMed:21138416, PubMed:23453971, PubMed:23453972, PubMed:23746807, PubMed:25636800, PubMed:26611359, PubMed:32404352, PubMed:34363755, PubMed:32298923). Following activation of toll-like receptors by viral or bacterial components, associates with TRAF3 a
Cytoplasm
Glaucoma 1, open angle, P
A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. GLC1P is characterized by early onset, thin central corneas and low intraocular pressure.
Molecular adapter required for selective macroautophagy (aggrephagy) by acting as a bridge between polyubiquitinated proteins and autophagosomes (PubMed:15340068, PubMed:15953362, PubMed:16286508, PubMed:17580304, PubMed:20168092, PubMed:22017874, PubMed:22622177, PubMed:24128730, PubMed:28404643, PubMed:29343546, PubMed:29507397, PubMed:31857589, PubMed:33509017, PubMed:34471133, PubMed:34893540, PubMed:35831301, PubMed:37306101, PubMed:37802024). Promotes the recruitment of ubiquitinated cargo
Cytoplasmic vesicle, autophagosomePreautophagosomal structureCytoplasm, cytosolNucleus, PML bodyLate endosomeLysosomeNucleusEndoplasmic reticulumCytoplasm, myofibril, sarcomere
Paget disease of bone 3
A disorder of bone remodeling characterized by increased bone turnover affecting one or more sites throughout the skeleton, primarily the axial skeleton. Osteoclastic overactivity followed by compensatory osteoblastic activity leads to a structurally disorganized mosaic of bone (woven bone), which is mechanically weaker, larger, less compact, more vascular, and more susceptible to fracture than normal adult lamellar bone.
Catalyzes the oxidative deamination of primary amines to the corresponding aldehydes with the concomitant production of hydrogen peroxide and ammonia (PubMed:12072962, PubMed:19764817, PubMed:239684, PubMed:8144586). Its preferred substrates are the diamines histamine and 1-methylhistamine and it could therefore play a role in allergic and immune responses (PubMed:12072962). Has a broad specificity for diamines and can also act on cadaverine and putrescine, two products of amino acid catabolism
Secreted, extracellular spaceCell membrane
Secreted ribonuclease that can either promote or restrict cell proliferation of target cells, depending on the context (PubMed:12051708, PubMed:1400510, PubMed:19332886, PubMed:20129916, PubMed:21855800, PubMed:23047679, PubMed:23843625, PubMed:2424496, PubMed:2459697, PubMed:2730651, PubMed:27518564, PubMed:28176817, PubMed:29100074, PubMed:29748193, PubMed:3122207, PubMed:32510170, PubMed:38718836, PubMed:8159680, PubMed:8570639, PubMed:8622921, PubMed:9578571). Endocytosed in target cells via
SecretedNucleusNucleus, nucleolusCytoplasm, Stress granule
Amyotrophic lateral sclerosis 9
A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.
RNA-binding protein that is involved in various steps of RNA biogenesis and processing (PubMed:23519609). Preferentially binds, via its two RNA recognition motifs RRM1 and RRM2, to GU-repeats on RNA molecules predominantly localized within long introns and in the 3'UTR of mRNAs (PubMed:23519609, PubMed:24240615, PubMed:24464995). In turn, regulates the splicing of many non-coding and protein-coding RNAs including proteins involved in neuronal survival, as well as mRNAs that encode proteins relev
NucleusCytoplasmCytoplasm, Stress granuleMitochondrion
Amyotrophic lateral sclerosis 10
A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.
Capable of hydrolyzing lactones and a number of aromatic carboxylic acid esters. Has antioxidant activity. Is not associated with high density lipoprotein. Prevents LDL lipid peroxidation, reverses the oxidation of mildly oxidized LDL, and inhibits the ability of MM-LDL to induce monocyte chemotaxis
Membrane
Neurofilaments usually contain three intermediate filament proteins: NEFL, NEFM, and NEFH which are involved in the maintenance of neuronal caliber. NEFH has an important function in mature axons that is not subserved by the two smaller NF proteins. May additionally cooperate with the neuronal intermediate filament proteins PRPH and INA to form neuronal filamentous networks (By similarity)
Cytoplasm, cytoskeletonCell projection, axon
Amyotrophic lateral sclerosis
A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.
Binds specifically to calcyclin in a calcium-dependent manner (By similarity). Required for midbody formation and completion of the terminal phase of cytokinesis
CytoplasmMelanosomeNucleus envelopeNucleus, nucleoplasmCytoplasm, cytoskeleton, spindle
Amyotrophic lateral sclerosis 23
A form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. ALS23 is an autosomal dominant form with incomplete penetrance.
Has low activity towards the organophosphate paraxon and aromatic carboxylic acid esters. Rapidly hydrolyzes lactones such as statin prodrugs (e.g. lovastatin). Hydrolyzes aromatic lactones and 5- or 6-member ring lactones with aliphatic substituents but not simple lactones or those with polar substituents
Secreted, extracellular space
May play a role in transcription or may interact with other nuclear matrix proteins to form the internal fibrogranular network. In association with the SFPQ-NONO heteromer may play a role in nuclear retention of defective RNAs. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:2871272
Nucleus matrix
Amyotrophic lateral sclerosis 21
A neurodegenerative disorder affecting upper and lower motor neurons, resulting in muscle weakness and respiratory failure. Some patients may develop myopathic features or dementia.
Part of the dynactin complex that activates the molecular motor dynein for ultra-processive transport along microtubules (By similarity). Plays a key role in dynein-mediated retrograde transport of vesicles and organelles along microtubules by recruiting and tethering dynein to microtubules. Binds to both dynein and microtubules providing a link between specific cargos, microtubules and dynein. Essential for targeting dynein to microtubule plus ends, recruiting dynein to membranous cargos and en
CytoplasmCytoplasm, cytoskeletonCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCytoplasm, cytoskeleton, spindleNucleus envelopeCytoplasm, cell cortex
Neuronopathy, distal hereditary motor, autosomal dominant 14
A form of distal hereditary motor neuronopathy, a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs.
Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation
Secreted, extracellular space
Microvascular complications of diabetes 5
Pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis.
Phosphorylates serines and threonines, but also appears to possess tyrosine kinase activity (PubMed:20230784). Involved in DNA damage checkpoint control and for proper DNA damage repair (PubMed:20230784). In response to injury that includes DNA damage, NEK1 phosphorylates VDAC1 to limit mitochondrial cell death (PubMed:20230784). May be implicated in the control of meiosis (By similarity). Involved in cilium assembly (PubMed:21211617)
NucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm
Short-rib thoracic dysplasia 6 with or without polydactyly
A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome.
Binds to actin and affects the structure of the cytoskeleton. At high concentrations, profilin prevents the polymerization of actin, whereas it enhances it at low concentrations. By binding to PIP2, it inhibits the formation of IP3 and DG. Inhibits androgen receptor (AR) and HTT aggregation and binding of G-actin is essential for its inhibition of AR
Cytoplasm, cytoskeleton
Amyotrophic lateral sclerosis 18
A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.
Involved in the packaging of pre-mRNA into hnRNP particles, transport of poly(A) mRNA from the nucleus to the cytoplasm and modulation of splice site selection (PubMed:17371836). Plays a role in the splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed:20010808). Binds to the IRES and thereby inhibits the translation of the apoptosis protease activating
NucleusCytoplasm
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3
An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance.
Plays a role in cilia formation and/or maintenance (By similarity). Plays a role in the regulation of cell morphology and cytoskeletal organization (PubMed:21834987). Involved in DNA damage repair (PubMed:26290490)
MitochondrionCytoplasm, cytoskeleton, cilium basal bodyCell projection, cilium, photoreceptor outer segmentCytoplasm
Retinal dystrophy with or without macular staphyloma
An ocular disorder characterized by decreased vision which worsen over time, and dystrophic changes in the retina, such as retinal pigment epithelium mottling and vessel narrowing. Macular staphyloma, without high myopia, is present in some patients.
Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The M
Cytoplasm, cytosolLate endosome membrane
Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
A neurodegenerative disorder characterized by frontotemporal dementia and/or amyotrophic lateral sclerosis in affected individuals. There is high intrafamilial variation. Frontotemporal dementia (FTD) is characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Amyotrophic lateral sclerosis (ALS) is characterized by the death of motor neurons in the brain, brainstem, and spinal cord, resulting in fatal paralysis. FTDALS7 is an autosomal dominant form characterized by onset of ALS or FTD in adulthood. A few patients may have both phenotypes.
Necessary for the fragmentation of Golgi stacks during mitosis and for their reassembly after mitosis. Involved in the formation of the transitional endoplasmic reticulum (tER). The transfer of membranes from the endoplasmic reticulum to the Golgi apparatus occurs via 50-70 nm transition vesicles which derive from part-rough, part-smooth transitional elements of the endoplasmic reticulum (tER). Vesicle budding from the tER is an ATP-dependent process. The ternary complex containing UFD1, VCP and
Cytoplasm, cytosolEndoplasmic reticulumNucleusCytoplasm, Stress granule
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance.
Plays a role in vesicle maturation during exocytosis as a target of the diacylglycerol second messenger pathway. Involved in neurotransmitter release by acting in synaptic vesicle priming prior to vesicle fusion and participates in the activity-dependent refilling of readily releasable vesicle pool (RRP). Essential for synaptic vesicle maturation in most excitatory/glutamatergic but not inhibitory/GABA-mediated synapses. Facilitates neuronal dense core vesicles fusion as well as controls the loc
CytoplasmCell membranePresynaptic cell membranePresynaptic active zone
DNA/RNA-binding protein that plays a role in various cellular processes such as transcription regulation, RNA splicing, RNA transport, DNA repair and damage response (PubMed:27731383). Binds to ssRNA containing the consensus sequence 5'-AGGUAA-3' (PubMed:21256132). Binds to nascent pre-mRNAs and acts as a molecular mediator between RNA polymerase II and U1 small nuclear ribonucleoprotein thereby coupling transcription and splicing (PubMed:26124092). Also binds its own pre-mRNA and autoregulates
Nucleus
Medicamentos e terapias
Mecanismo: SOD1 mRNA antisense inhibitor
Mecanismo: Sodium channel alpha subunit blocker
Mecanismo: Insulin-like growth factor I receptor agonist
Mecanismo: Sodium channel alpha subunit blocker
Variantes genéticas (ClinVar)
291 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 8,784 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
172 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Esclerose lateral amiotrófica
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
🟢 Recrutando agora
20 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
Publicações mais relevantes
Mostrando amostra de 200 publicações de um total de 21.066
Muscle MRI and Muscle Ultrasound Applications in MND/ALS: Academic Insights and Clinical Opportunities.
Este artigo destaca que, embora a deficiência na ELA seja primariamente muscular, a imagem dos músculos tem sido uma área negligenciada como biomarcador para a doença. No entanto, uma revisão sistemática demonstrou que técnicas não-invasivas como ressonância magnética e ultrassom são eficazes na detecção da degeneração muscular característica da ELA, avaliando desde volume e conteúdo de gordura até fasciculações. Essa é uma oportunidade valiosa para médicos e pacientes, pois esses métodos, de fácil implementação, podem aprimorar o diagnóstico, monitorar a progressão e avaliar a resposta a tratamentos para a ELA.
🇧🇷 traduzidoSleep Disorders in Neurodegenerative Diseases: Pathological Correlations and Underlying Mechanisms.
Para pacientes e médicos, é crucial saber que: Pacientes com Esclerose Lateral Amiotrófica (ELA), assim como em outras doenças neurodegenerativas, frequentemente sofrem de distúrbios do sono significativos. Contudo, esses distúrbios não são apenas uma consequência da ELA, mas também podem exacerbar sua progressão, numa relação bidirecional complexa. Consequentemente, o tratamento eficaz desses distúrbios do sono é crucial, pois pode proporcionar alívio sintomático e até mesmo ter efeitos modificadores na doença.
🇧🇷 traduzidoEmbedded CRISPRi Enhances Gene-Silencing Efficiency in Drosophila.
Cientistas desenvolveram um novo método, chamado emCRISPRi, que aprimora drasticamente a capacidade de "desligar" genes específicos, uma ferramenta crucial para entender e combater doenças. Esta nova abordagem mostrou-se particularmente eficaz na redução da toxicidade causada pela proteína TDP-43, um fator chave na Esclerose Lateral Amiotrófica (ELA), em um modelo de laboratório. Essas descobertas representam um avanço promissor no estudo da ELA, com potencial significativo para o desenvolvimento futuro de novas terapias e uma melhor compreensão da doença.
🇧🇷 traduzidoSubcortical microstructural impairment in amyotrophic lateral sclerosis: clinical correlates of neurite orientation dispersion and density imaging (NODDI) changes.
Este estudo investigou a microestrutura de regiões cerebrais profundas em pacientes com Esclerose Lateral Amiotrófica (ELA) usando uma técnica avançada de ressonância magnética (NODDI). Não foram encontradas diferenças microestruturais robustas entre pacientes e controles, e as associações observadas entre a microestrutura dessas áreas e os sintomas da ELA (respiratórios, motores) foram apenas preliminares e não estatisticamente confirmadas. Isso sugere a necessidade de mais pesquisas em grupos maiores para entender melhor o papel dessas regiões na doença.
🇧🇷 traduzidoSmall heat shock proteins HspB1 and HspB5 differentially alter the condensation and aggregation of the TDP-43 low-complexity domain.
Em doenças neurodegenerativas como a Esclerose Lateral Amiotrófica (ELA), a proteína TDP-43 se condensa e agrega de forma prejudicial. Este estudo demonstrou que as proteínas HspB1 e HspB5 atuam como "chaperones", regulando a condensação da TDP-43 e prevenindo sua agregação tóxica, embora com mecanismos ligeiramente diferentes. Esses achados são de grande relevância, pois identificam HspB1 e HspB5 como potenciais alvos terapêuticos para o desenvolvimento de tratamentos que possam mitigar a formação de agregados tóxicos de TDP-43 em pacientes.
🇧🇷 traduzidoPublicações recentes
CAR Treg therapies for neurodegenerative diseases.
The effect of statins on the survival of patients with amyotrophic lateral sclerosis: a meta-analysis.
Nuclear export modulates TDP-43 phase transitions and cytoplasmic aggregation.
A region-delineated snRNA-seq atlas of mouse spinal cord across lifespan resolves the interaction of normative aging programs with SOD1-G93A ALS.
Microprotein Regulates G-quadruplex Driven RNA Aggregation.
📚 EuropePMC17.515 artigos no totalmostrando 198
Muscle MRI and Muscle Ultrasound Applications in MND/ALS: Academic Insights and Clinical Opportunities.
European journal of neurologyA phase I study to evaluate the dosimetry and safety of [89Zr]Zr-DFO-AP-101, a new antibody-based radiopharmaceutical to detect misfolded SOD1 in amyotrophic lateral sclerosis.
European journal of nuclear medicine and molecular imagingClinical and Sociodemographic Profile of Familial Amyotrophic Lateral Sclerosis Type 8 Compared to the Sporadic Form.
Arquivos de neuro-psiquiatriaRole of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches.
Molecular neurobiologyA Qualitive Investigation of Geographic Disparities in Genetic Testing and Care Access for Amyotrophic Lateral Sclerosis: Insights From Patient Journey Mapping.
Patient preference and adherencePredicting Disease Progression and Survival in Amyotrophic Lateral Sclerosis.
Muscle & nerveSleep Disorders in Neurodegenerative Diseases: Pathological Correlations and Underlying Mechanisms.
Neuroscience bulletinUncoupling of apnea-hypopnea index and oxygen desaturation in als: characterization and diagnostic implications of an "AHI-SpO₂ dissociation" phenotype.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyThe p75NTR Signaling Axis: Bridging Neurodevelopmental Homeostasis, Pathological Mechanisms, and Therapeutic Strategies in Neurodegenerative Diseases.
Ageing research reviewsAssociations between pre-disease biomarkers of persistent organic pollutants and amyotrophic lateral sclerosis risk in four European cohorts.
Environmental researchDecoding Neuroinflammatory Pathways: The Role of the CXCL12-CXCR4/CXCR7 Axis in ALS-Related Cognitive Impairment.
Molecular neurobiologyTargeting Autophagy with Bioactive Compounds: Therapeutic Potential in Neurodegenerative Disorders.
Current neuropharmacologyALS mutations disrupt self-association between the ubiquilin STI1 hydrophobic groove and internal placeholder sequences.
The EMBO journalEmbedded CRISPRi Enhances Gene-Silencing Efficiency in Drosophila.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)[Protective effect of a CREB3 gain-offunction variant in amyotrophic lateral sclerosis].
Medecine sciences : M/SSubcortical microstructural impairment in amyotrophic lateral sclerosis: clinical correlates of neurite orientation dispersion and density imaging (NODDI) changes.
Frontiers in neuroscienceRegistered Dietitians' perspectives on nutrition management of persons living with amyotrophic lateral sclerosis.
Neurodegenerative disease managementPlasma proteomic trajectories before the onset of neurodegenerative diseases.
Neurodegenerative disease managementRepeat expansion RNA elicits toxicity through hybrid G-quadruplexes with promoter DNA.
NeuronSmall heat shock proteins HspB1 and HspB5 differentially alter the condensation and aggregation of the TDP-43 low-complexity domain.
Protein science : a publication of the Protein SocietyIdentifying priorities for a national motor neurone disease (amyotrophic lateral sclerosis) guideline: results from an Australian online survey.
Disability and rehabilitationHerpesvirus genome integration in whole-genome sequences of dementia and control cohorts.
Alzheimer's & dementia : the journal of the Alzheimer's AssociationSystemic dysregulation of apolipoproteins in amyotrophic lateral sclerosis serum.
FEBS open bioHigh Prevalence of SOD1 Pathogenic Variants in the UK Biobank: Implications for Early Intervention in Amyotrophic Lateral Sclerosis.
Annals of neurologyAuthor Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis.
NatureParaspeckle condensation is controlled via TDP-43 polymerization and linked to neuroprotection.
Nature cell biologyImplanted brain-computer interface functionality during nighttime in late-stage amyotrophic lateral sclerosis.
Scientific reportsReduced nuclear TDP-43 and cytoplasmic DLK1 as markers of motor neuron degeneration in amyotrophic lateral sclerosis.
Journal of neuropathology and experimental neurologyIdentification of tofersen PD-response biomarkers in VALOR clinical trial CSF via multiplexed quantitative proteomics.
Cell reports. MedicineEmploying an integrated computational simulation strategy to identify high-affinity ligands for TDP-43 amyloid proteins.
Bioorganic & medicinal chemistryFrom observation to optimization: behavioral metrics that matter in KPI based home cage monitoring.
Frontiers in behavioral neuroscienceSarcopenia in amyotrophic lateral sclerosis: a key predictor of respiratory dysfunction and disease progression.
Frontiers in nutritionFrom Refractory Epilepsy to Neurodegeneration: Emerging Mechanistic and Clinical Insights Into the Ketogenic Diet.
FASEB journal : official publication of the Federation of American Societies for Experimental BiologyThe role of IRF5 in Microglia-Mediated neuroinflammation in ALS.
Neuroscience lettersThe role of TDP-43 fragments in regular cellular functions and homeostatic failure.
Neurobiology of diseaseALS motor phenotypes: a revised 'OPM' classification.
Amyotrophic lateral sclerosis & frontotemporal degenerationSexual health in neuromuscular diseases: Neglected challenges revealed by a scoping review.
Journal of neuromuscular diseasesValosin-containing protein counteracts ATP-driven dissolution of FUS condensates through its ATPase activity in vitro.
FEBS lettersRestoring rapid natural bimanual typing with a neuroprosthesis after paralysis.
Nature neuroscienceHigh-throughput screening of ALS patient iPSC-derived spinal motor neurons identifies novel compounds that increase neurofilament light chain expression.
SLAS discovery : advancing life sciences R & DLumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice.
Journal of visualized experiments : JoVEComparing vowel intelligibility across interactive and non-interactive tasks in disordered speech.
JASA express lettersLocal Translation in Glial Cells of the Brain.
Annual review of cell and developmental biologyTDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis.
Acta neuropathologicaSafety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial.
JAMA neurologyUbiquitin signatures on aggregating proteins in neurodegeneration.
Essays in biochemistryDecoding neurodegeneration one cell at a time.
The Journal of clinical investigationSplicing the narrative: alternative TARDBP splicing and its relation to neurodegeneration in ALS and FTD.
The Journal of clinical investigationConsequences of the Novel ALS-Associated KIF5A Variant c.2993-6C > A for Exon 27 Splicing and Axonal Transport of SFPQ.
Neurology. GeneticsApproaching Serious Illness Conversations in Amyotrophic Lateral Sclerosis Using Telehealth: A Practical Guide.
Neurology. Clinical practiceFunctional validation of the novel KIF5A p.R17Q VUS reveals defective axonal transport in iPSC-motoneurons from a SPG10 patient.
Frontiers in geneticsAutophagy-exosome crosstalk in neurodegeneration: Mechanisms and therapeutic opportunities.
Pharmacology & therapeuticsThe role of zinc transporter 1 (ZnT1) in health and disease: From molecular mechanisms to therapeutic opportunities.
European journal of medicinal chemistryAnalysis of immune-related alterations in blood and spinal cord of canine degenerative myelopathy, a spontaneous model of amyotrophic lateral sclerosis.
Scientific reportsHuman FUS is toxic via association with RNA polymerase II in Drosophila.
Cell death & diseaseAldh3a1-mediated detoxification of reactive aldehydes contributes to distinct muscle responses to amyotrophic lateral sclerosis progression.
Free radical biology & medicineTranslating neurofilament light chain testing into clinical practice: a multidisciplinary implementation roadmap.
Clinical chemistry and laboratory medicineFrom Environment to Symptoms: Mapping Premorbid Risk Factors onto Clinical Features of ALS in a Patient-Reported Database in China.
Neurology and therapyPatientFlow: Learning to generate mixed-type longitudinal clinical data with flow matching.
Artificial intelligence in medicinePropensity Score-Based Stratified Win Ratio for Augmented Control Designs.
Statistics in medicineHML-2 env knockdown by AAV9-mediated miRNAs attenuates amyotrophic lateral sclerosis-like manifestations in mice.
Brain : a journal of neurologyQuantification of Tongue Motor Dysfunction in Amyotrophic Lateral Sclerosis Using a Smartphone-Based Task and Deep Learning.
Sensors (Basel, Switzerland)Motor Neuron Disease with Guillain-Barré Syndrome? Motor Band Sign with Anti-GQ1b Antibodies.
Diagnostics (Basel, Switzerland)TBK1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Mechanistic Insights into Impaired Autophagy and Proteostatic Failure.
CellsTIA1 Mutant Mouse Model Exhibits Motor Deficits and Neurodegenerative Characteristics of Amyotrophic Lateral Sclerosis.
CellsThe evolution of speech communication devices for anarthria: a review.
Journal of neurologyAssessing green space exposure: From traditional metrics to the Green Exposure Index (GEI) with application to a Northern Italy residential dataset.
Environmental researchThe role of MyD88 in the nervous system: Neuronal functions, implications in neurological diseases, and therapeutic potential.
Pharmacology & therapeuticsReversibility and β-sheet formation are decoupled in tau condensate aging.
Proceedings of the National Academy of Sciences of the United States of AmericaFerritin in ferroptosis: Implications for neurodegenerative diseases (Review).
International journal of molecular medicineImmunotherapies for risk reduction in age-associated neurodegenerative diseases: impact of sex and treatment duration.
medRxiv : the preprint server for health sciencesAn Unsuspected Intraneural Perineurioma in a Pediatric Patient: A Case Report.
CureusPlasma isomiRs as Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Neurology. GeneticsTofersen treatment in SOD1 p.Leu145Phe ALS: real-world outcomes in a genetically homogeneous Croatian cohort.
Amyotrophic lateral sclerosis & frontotemporal degenerationSerum Trace Elements and Their Associations with Disease Progression and Survival in Sporadic Amyotrophic Lateral Sclerosis: Insights from a Chinese Cohort.
Biomedical and environmental sciences : BESImmune imbalance between T helper 1, T helper 17 and regulatory T cells fuels amyotrophic lateral sclerosis pathogenesis: disease trajectory, diagnosis and therapeutic implications.
Journal of neuroinflammationAn Unusual Presentation of Juvenile Amyotrophic Lateral Sclerosis with Superoxide Dismutase 1 Mutation: Subacute Bulbar Palsy With Asymmetric Limb Weakness.
Annals of Indian Academy of NeurologyMotoneurons inhibitory synapses homeostatically respond to neuronal activity and modulate Amyotrophic Lateral Sclerosis pathogenesis.
The Journal of neuroscience : the official journal of the Society for NeuroscienceRespiratory alterations in patients with amyotrophic lateral sclerosis.
Medicina clinicaTargeting PGAM5-driven mitochondrial integrated stress response slows ALS progression across subtypes.
NeuronEffect of G4C2repeat expansions on the motion of lysosomes inside neurites.
Physical biologyAdvancement in therapeutic application of quantum dots in amyotrophic lateral sclerosis: current opportunities and challenges.
Drug delivery and translational researchNon-invasive ventilation support during feeding tube placement in amyotrophic lateral sclerosis patients with moderate to severe ventilatory impairment: an update.
Panminerva medicaOral Health in Amyotrophic Lateral Sclerosis: Feasibility of Oral Screening and Determinants of Poor Outcomes.
Muscle & nerveOral Health Care Services, Barriers and Enablers to Maintaining Good Oral Health in Motor Neurone Disease: A Scoping Review.
Community dentistry and oral epidemiologyIdentification of drug repurposing candidates for amyotrophic lateral sclerosis using electronic health records: a retrospective cohort study.
The Lancet. Digital healthALS and Huntington Disease: Unraveling the Connections between TDP-43 and Huntingtin.
The Journal of neuroscience : the official journal of the Society for NeuroscienceSpinal motoneuron excitability is homeostatically regulated through β-adrenergic neuromodulation in wild-type and presymptomatic SOD1 mice.
Progress in neurobiologyPAICS mediates DNA damage and cerebellar neuronal loss in C9orf72 amyotrophic lateral sclerosis.
Brain : a journal of neurologyInnovation, Adaptation, and Human Dignity in Assistive Robotics in Amyotrophic Lateral Sclerosis: A Rehabilitation Medicine Perspective.
Journal of biotechnology and biomedicineMesenchymal stem cells and the central nervous system: historical perspectives and future directions.
Frontiers in molecular neurosciencecGAS inhibition delays TDP-43-driven ALS Pathogenesis.
bioRxiv : the preprint server for biologyDistinct Prescription Patterns Emerge Years Before ALS Diagnosis: A Nationwide Registry-Based Study.
Annals of neurologyFructose-2,6-bisphosphate restores TDP-43 pathology-driven genome repair deficiency in motor neuron diseases.
Communications biologyTDP-43 pathology triggers neuroinflammation and cognitive impairment by inducing microglial necroptosis.
EMBO molecular medicineLong-wave infrared imaging for respiratory rate measurement in a patient with amyotrophic lateral sclerosis: A case report.
The Journal of international medical researchUbiquitin-specific peptidase-19 links TDP-43 aggregation to ER stress.
Proceedings of the National Academy of Sciences of the United States of AmericaHow to measure person-centred care in people living with ALS: development and validation of the patient experience PEMALS questionnaire.
Amyotrophic lateral sclerosis & frontotemporal degenerationCofilin hyperphosphorylation triggers TDP-43 pathology in sporadic amyotrophic lateral sclerosis.
Brain : a journal of neurologyPml loss worsens NEK1-linked ALS and Pml induction drives NEK1 degradation, precluding disease onset.
The FEBS journal[Immune Cells and Proteins Associated with Disease Progression in Amyotrophic Lateral Sclerosis: New Insights from Multiomics Analyses].
Brain and nerve = Shinkei kenkyu no shinpoMotor neuron disease can present as a paraneoplastic neurologic syndrome with various phenotypes.
Brain communicationsExercise pressor reflex in Amyotrophic lateral sclerosis patients.
Scientific reportsMulti-modal dissection of cell-type specific TDP-43 pathology in the motor cortex.
Nature communications"A rough and swirling sea": Voicing Amyotrophic Lateral Sclerosis through discourse analysis.
Journal of health psychologyClinical Validation of Plasma p-217tau in Neurological Diseases.
Annals of clinical and translational neurologyKenny is the adaptor protein for ubiquitin-dependent mitophagy in Drosophila melanogaster.
Autophagy reportsAn electrochemical enzyme-linked immunosorbent assay for interleukin 18 quantification in 3D skin models derived from ALS patients.
Biosensors & bioelectronicsRNA-Binding Proteins TDP-43 and FUS Promote R-Loop Resolution and Regulate Transcription Termination.
The Journal of biological chemistryUnraveling amyotrophic lateral sclerosis: a novel peripherin mutation in a young male with sporadic onset.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyALS untangled #83: clenbuterol.
Amyotrophic lateral sclerosis & frontotemporal degenerationBrain Folding Trajectories in Amyotrophic Lateral Sclerosis.
Human brain mappingDecoding the functions of nuclear speckles in neurodegeneration.
Trends in neurosciencesIntegrating Serum Neurofilament Light Chain Into Amyotrophic Lateral Sclerosis Diagnostic Criteria.
Muscle & nerveCell-free miRNAs are pharmacodynamic biomarkers for enhanced DICER activity by enoxacin in human patients with ALS.
Molecular therapy : the journal of the American Society of Gene TherapyExpanding the Motor Band Sign in Motor Neuron Disease Using 7T MRI: Visualization of Cortical Layer-Dependent Iron Deposition in the Primary Motor Cortex.
Muscle & nerveImpairment of brain short association fibers across clinical stages in amyotrophic lateral sclerosis: a new biomarker mirroring disease progression.
BMC medicineCalprotectin as an immune-dysregulation biomarker in amyotrophic lateral sclerosis: Insights for diagnosis and therapy.
Revue neurologiquePathogenic VCP (p.Arg453Trp) variant in three siblings with frontotemporal dementia-amyotrophic lateral sclerosis spectrum: A Turkish family.
Clinical neurology and neurosurgeryUnveiling the entropic role of hydration water in SOD1 partitioning within FUS condensate.
The Journal of chemical physics"What about me? I'm supposed to be … superhuman?": exploring staff perspectives on how to deliver high quality psychological care for people living with amyotrophic lateral sclerosis.
Neurodegenerative disease management3D Artificial Skin Model As a Novel Strategy for the Detection of Pyroptosis-Cascade Activation in Amyotrophic Lateral Sclerosis.
ACS applied materials & interfacesBrain organoids as precision models for neurodegenerative diseases: from disease modeling to drug discovery.
Frontiers in neuroscienceHypothesis-free evaluation of circulating metabolome provides cell-specific insights regarding the role of energy substrate availability in amyotrophic lateral sclerosis.
BMC medicineSubjective sleep quality in amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Amyotrophic lateral sclerosis & frontotemporal degenerationBridging the gap: understanding participation barriers in ALS clinical trials through on-the-ground insights.
Amyotrophic lateral sclerosis & frontotemporal degenerationGadolinium enhancement of the cauda equina in a case of familial ALS with p.S135G SOD1 mutation.
Amyotrophic lateral sclerosis & frontotemporal degenerationExploring the use of narrative-based approaches in individuals with amyotrophic lateral sclerosis: A narrative review.
Palliative & supportive careCopper Homeostasis and Cuproptosis in Neurological Disorders.
Drug design, development and therapyGlioinflammation: disease-associated microglia and astrocytes in psychiatric disorders, neurodegeneration, and senescence.
Frontiers in cellular neuroscienceBrain Organoids as Emerging Platforms for Modeling Neurodegenerative Diseases: Progress, Challenges, and Future Directions.
Journal of neurochemistryComparison of AAV9-driven motor neuron transduction following different CNS-directed delivery methods in mice.
Scientific reportsDecreased metallothionein-3 expression in the human spinal cord is a common feature of amyotrophic lateral sclerosis and multiple sclerosis.
Scientific reportsTDP-43 phosphorylation: Exploring kinases, phosphatases, and therapeutic potential in neurodegeneration.
Journal of Alzheimer's disease : JADMesenchymal stem cell therapies for neurodegenerative diseases: Advancements, challenges, and opportunities.
Neural regeneration researchUnlocking amyotrophic lateral sclerosis diagnosis: How artificial intelligence is transforming early prediction.
Neural regeneration researchALSUntangled #82: N-acetylcysteine.
Amyotrophic lateral sclerosis & frontotemporal degenerationProteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival.
Brain pathology (Zurich, Switzerland)Disruption of the angiopoietin-like system connects lipid homeostasis and hypothalamic dysfunction in ALS.
BMC medicineIntranasal administration of human mesenchymal stromal cell-derived small extracellular vesicles delays disease progression in the SOD1(G93A) mouse model.
Molecular brainExploring the Lived Experiences of Individuals with Amyotrophic Lateral Sclerosis (ALS): A Qualitative Study and Conceptual Model of Signs, Symptoms, and Functional Impacts.
Neurology and therapyFrom scaffold to effector: reframing GFAP in neurodegeneration.
Journal of advanced researchA tri-responsive sensor based on co-encapsulated organic probes and multifunctional bimetallic V/Ce-MOF nanozyme in a hydrogel for the detection of l-Serine in saliva.
TalantaFUS is an N1- and N6-methyladenosine-binding protein.
Nucleic acids researchLoss of Splicing Homeostasis as a Hallmark of Aging.
Molecular and cellular biologyGranules Gone Rogue: Nuclear and Cytoplasmic Ribonucleoprotein Structures in Amyotrophic Lateral Sclerosis-Fused in Sarcoma (ALS-FUS) Pathology.
Molecular neurobiologyNeuroViOme: a viral orfeome collection for studies of neurodegenerative disease.
Journal of neurovirologyThe Amyotrophic Lateral Sclerosis House Call Program: A Single-Center Experience in the United States.
Neurology research internationalMoral decision-making in patients with neurodegenerative diseases: a systematic review.
Frontiers in psychologyHeat shock proteins (Hsp70 and Hsp90) in neurodegeneration: pathogenic roles and therapeutic potential.
Frontiers in aging neuroscienceAmyotrophic Lateral Sclerosis Caused by a Pathogenic Variant in SOD1 Gene: An Atypical Rapidly Progressive Phenotype.
Journal of clinical neuromuscular diseaseRespiratory Onset Amyotrophic Lateral Sclerosis in a Patient With C9orf72 Expansion.
Journal of clinical neuromuscular diseaseExploring Intimacy in Amyotrophic Lateral Sclerosis: A Pilot Study of Educational Support in a Multidisciplinary Clinic.
Journal of clinical neuromuscular diseaseVoxel-mirrored homotopic connectivity in upper motor neuron-dominant amyotrophic lateral sclerosis is associated with different spread directions.
Brain imaging and behavior[Mechanism of action and clinical trial results of a new drug for amyotrophic lateral sclerosis (ALS), Mecobalamin (Rozebalamin®) for intramuscular injection, 25 mg].
Nihon yakurigaku zasshi. Folia pharmacologica JaponicaVoltage-gating and neuronal signalling in neurodegeneration: From neuropathology to therapeutic opportunities in motor neuron disease.
Neurobiology of diseaseNeuroinflammation and Oxidative Stress in SOD1 Animal Models of ALS: A Meta-analysis Study of Their Effects on Disease Onset and Progression.
Molecular neurobiologyModeling the growth of cytosolic TDP-43 inclusion bodies and accumulated neurotoxicity of misfolded oligomers in neurons.
Computer methods in biomechanics and biomedical engineeringSmall extracellular vesicles as emerging biomarkers and therapeutic targets in neurodegenerative diseases.
Clinica chimica acta; international journal of clinical chemistryGinsenoside compound K inhibited the gelation of GGGGCC repeats and regulated co-aggregation with arginine-rich poly-dipeptides in C9orf72-related ALS.
International journal of biological macromoleculesConstitutive neuronal expression and disease-associated upregulation of chitinases in amyotrophic lateral sclerosis.
Brain : a journal of neurologyPatient and caregiver attitudes to cognitive and behavioral testing in Amyotrophic Lateral Sclerosis.
Neurodegenerative disease managementAdvances and Challenges in the Use of Spinal Cord Organoids in ALS.
Journal of integrative neurosciencePreferences for Healthcare Delivery in Amyotrophic Lateral Sclerosis (ALS): A Survey of Patients and Caregivers in the United States.
The patientKIF5A and ALS: a clinical and genetic description of a case series and review of literature.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologySafety and biodistribution of intrathecal administration of mesenchymal stem cells (MSCs) and neurotrophin-releasing nanoparticles in a porcine CSF-guided delivery model for amyotrophic lateral sclerosis (ALS) drug discovery.
Scientific reportsC9orf72-ALS mutation drives basal mitophagy impairments in iNeurons.
Frontiers in cellular neuroscienceHuman CSF proteogenomics links genetic variation to neurodegenerative disease proteins.
medRxiv : the preprint server for health sciencesNeuronal Cell-Cycle Re-entry Defines Divergent Outcomes Through Replication-Dependent DNA Damage in ALS.
bioRxiv : the preprint server for biologyAutophagy induction mitigates FUS aggregate formation and early synaptic dysfunction at the NMJ in the FUS-ALS model.
bioRxiv : the preprint server for biologyReversing Mitochondrial Dysfunction in Optineurin E50K Glaucoma: A Metabolic Approach to Neuroprotection.
Research squareAntidepressant-Like Effects of n-Butylidenephthalide Using In Vivo and In Silico Approaches.
Pharmaceuticals (Basel, Switzerland)Impact of Built-In Software Monitoring on Survival in Amyotrophic Lateral Sclerosis Patients Receiving Home Mechanical Ventilation: A Cohort Study.
Journal of clinical medicineAmyotrophic Lateral Sclerosis (ALS) Genetics and Microbiota: A Comprehensive Review.
International journal of molecular sciencesAntisense Dipeptide Repeat Proteins Drive Widescale Purine Metabolism Aberration in C9orf72 Amyotrophic Lateral Sclerosis via ADA.
International journal of molecular sciencesPPAR-Delta Agonist Therapies Did Not Rescue Hallmark Disease Phenotypes in Two Sets of Preclinical Trials in ALS TDP-43 and C9orf72 Model Mice.
International journal of molecular sciencesAmyotrophic Lateral Sclerosis: The State of the Art on Treatments and the Therapeutic Role of the Intestinal Microbiome in Human Studies.
International journal of molecular sciencesMesenchymal Stem Cell-Based Therapies Applied in Neurological Diseases: A Systematic Review.
BiomedicinesAn Artificial Intelligence-Driven Multimorbidity Framework Reveals a Shared Metabolic and Immune Core Across Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
BiomedicinesAbsence of Neuromuscular Dysfunction in Mice with Gut Epithelium-Restricted Expression of ALS Mutation hSOD1G93A.
BiomoleculesExploring the ALS Multistep Model.
Brain sciences'Molecular and Cellular Neuroscience': Impacts of Eight Highly Cited Articles Published in This Section of Brain Sciences in 2024.
Brain sciencesEnlarged Perivascular Spaces (EPVS) and the Risk of Amyotrophic Lateral Sclerosis (ALS): Evidence for Overlapping Genetic Signals in White Matter Without Causal Links.
Brain sciencesNomogram prediction model for prognosis of patients with amyotrophic lateral sclerosis.
BMC neurologyCorrigendum to "Chronic exposure to l-BMAA cyanotoxin induces cytoplasmic TDP-43 accumulation and glial activation, reproducing an amyotrophic lateral sclerosis-like phenotype in mice" [Biomed. Pharmacother. 167 (2023) 115503].
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapieMaximal motor unit firing rates decline with amyotrophic lateral sclerosis progression.
Clinical neurophysiology : official journal of the International Federation of Clinical NeurophysiologySafety profile of tofersen in amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyRole of mitochondria in neuronal function and survival in the enteric and central nervous systems.
Cellular and molecular life sciences : CMLSBlood Lactate as a Prognostic Biomarker for Survival and Weight Loss in Amyotrophic Lateral Sclerosis: An Exploratory-Validation Study.
Annals of neurologyPrevalence and Risk Factors of Dysphagia in Amyotrophic Lateral Sclerosis: A Retrospective Study Using the Nationwide Inpatient Sample Database.
Muscle & nerveVisualization analysis of the use of traditional Chinese medicine in the diagnosis and treatment of rare diseases in mainland China based on CiteSpace.
Intractable & rare diseases researchCurrent status and future prospects of brain-computer interfaces in the field of neurological disease rehabilitation.
Frontiers in rehabilitation sciencesDevelopment and pilot testing of U1 Adaptor therapy targeting SOD1 expression for dogs with degenerative myelopathy.
Journal of veterinary internal medicineFast and slow strains of misfolded mutant superoxide dismutase 1 in familial amyotrophic lateral sclerosis.
Acta neuropathologica communicationsTarget-stabilized base editors enable robust high-fidelity RNA editing.
Nature communicationsThe role of dentists in the recognition of neurodegenerative and systemic conditions with neurological involvement.
Oral surgery, oral medicine, oral pathology and oral radiologyProfiling mitochondrial DNA indices across whole blood, plasma, and CSF in amyotrophic lateral sclerosis.
Journal of the neurological sciencesNeuronal TDP-43 regulates myelin formation via neurexin 1 mRNA stabilization.
Proceedings of the National Academy of Sciences of the United States of AmericaAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Associação brasileira dedicada a Esclerose lateral amiotrófica (ELA).
Associação brasileira dedicada a Esclerose lateral amiotrófica (ELA).
Associação brasileira dedicada a Esclerose lateral amiotrófica (ELA).
Associação brasileira dedicada a Esclerose lateral amiotrófica (ELA).
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Esclerose lateral amiotrófica
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Muscle MRI and Muscle Ultrasound Applications in MND/ALS: Academic Insights and Clinical Opportunities.
- Sleep Disorders in Neurodegenerative Diseases: Pathological Correlations and Underlying Mechanisms.
- Embedded CRISPRi Enhances Gene-Silencing Efficiency in Drosophila.
- Subcortical microstructural impairment in amyotrophic lateral sclerosis: clinical correlates of neurite orientation dispersion and density imaging (NODDI) changes.
- Small heat shock proteins HspB1 and HspB5 differentially alter the condensation and aggregation of the TDP-43 low-complexity domain.
- CAR Treg therapies for neurodegenerative diseases.
- The effect of statins on the survival of patients with amyotrophic lateral sclerosis: a meta-analysis.
- Nuclear export modulates TDP-43 phase transitions and cytoplasmic aggregation.
- A region-delineated snRNA-seq atlas of mouse spinal cord across lifespan resolves the interaction of normative aging programs with SOD1-G93A ALS.
- Microprotein Regulates G-quadruplex Driven RNA Aggregation.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:803(Orphanet)
- MONDO:0004976(MONDO)
- Esclerose Lateral Amiotrofica(PCDT · Ministério da Saúde)
- GARD:5786(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Artigo Wikipedia(Wikipedia)
- Q206901(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
